Feng Dai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Feng Dai has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Daniel E. Weeks
Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
2 shared publications - David C. Whitcomb
University of Pittsburgh and UPMC
1 shared publication - Guangyun Sun
Center for Genome Information, Department of Environmental Health, University of Cincinnati, Cincinnati, OH 45267, USA
1 shared publication Janette Lamb
Departments of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA
1 shared publication- John Tuitele
Tafuna Family Health Center, Department of Health, American Samoa Government, Pago Pago, 96799, American Samoa
1 shared publication - Karolina A. Aberg
Center for Biomarker Research and Precision Medicine, Virginia Commonwealth University, Richmond, VA, USA
1 shared publication
Latest Publications
- Open Access
- 23 October 2009
- Published by Springer Nature in BMC Medical Genetics
- Vol. 10 (1) , 107
Suggestive linkage detected for blood pressure related traits on 2q and 22q in the population on the Samoan islands
Background: High blood pressure or hypertension is a major risk factor involved in the development of cardiovascular diseases. We conducted genome-wide variance component linkage analyses to search for loci influencing five blood pressure related traits including the quantitative traits systolic blood pressure (SBP), diastolic blood pressure (DBP) and pulse pressure (PP), the dichotomous trait hypertension (HT) and the bivariate quantitative trait SBP-DBP in families residing in American Samoa and Samoa, as well as in the combined sample from the two polities. We adjusted the traits for a number of environmental covariates such as smoking, alcohol consumption, physical activity and material life style. Results: We found suggestive univariate linkage for SBP on chromosome 2q35-q37 (LOD 2.4) and for PP on chromosome 22q13 (LOD 2.2), two chromosomal regions that recently have been associated with SBP and PP, respectively. Conclusion: We have detected additional evidence for a recently reported locus associated with SBP on chromosome 2q and a susceptibility locus for PP on chromosome 22q. However, differences observed between the results from our three partly overlapping genetically homogenous study samples from the Samoan islands suggest that additional studies should be performed in order to verify these results.
- 23 October 2009
- Published by Springer Nature in BMC Medical Genetics
- Vol. 10 (1) , 107
Open AccessSuggestive linkage detected for blood pressure related traits on 2q and 22q in the population on the Samoan islands
Background: High blood pressure or hypertension is a major risk factor involved in the development of cardiovascular diseases. We conducted genome-wide variance component linkage analyses to search for loci influencing five blood pressure related traits including the quantitative traits systolic blood pressure (SBP), diastolic blood pressure (DBP) and pulse pressure (PP), the dichotomous trait hypertension (HT) and the bivariate quantitative trait SBP-DBP in families residing in American Samoa and Samoa, as well as in the combined sample from the two polities. We adjusted the traits for a number of environmental covariates such as smoking, alcohol consumption, physical activity and material life style. Results: We found suggestive univariate linkage for SBP on chromosome 2q35-q37 (LOD 2.4) and for PP on chromosome 22q13 (LOD 2.2), two chromosomal regions that recently have been associated with SBP and PP, respectively. Conclusion: We have detected additional evidence for a recently reported locus associated with SBP on chromosome 2q and a susceptibility locus for PP on chromosome 22q. However, differences observed between the results from our three partly overlapping genetically homogenous study samples from the Samoan islands suggest that additional studies should be performed in order to verify these results.
- Open Access
- 1 January 2008
- Published by SAGE Publications in Molecular Pain
- Vol. 4, 58
Does the Pain-Protective GTP Cyclohydrolase Haplotype Significantly Alter the Pattern or Severity of Pain in Humans with Chronic Pancreatitis?
Background: Pain is often a dominant clinical feature of chronic pancreatitis but the frequency and severity is highly variable between subjects. We hypothesized that genetic polymorphisms contribute to variations in clinical pain patterns. Since genetic variations in the GTP cyclohydrolase (GCH1) gene have been reported to protect some patients from pain, we investigated the effect of the “pain protective haplotype” in well characterized patients with chronic pancreatitis (CP) or recurrent acute pancreatitis (RAP) from the North American Pancreatitis Study 2 (NAPS2). Results: Subjects in the NAPS2 study were asked to rank their pain in one of 5 categories reflecting different levels of pain frequency and severity. All subjects were genotyped at rs8007267 and rs3783641 to determine the frequency of the GCH1 pain-protective haplotype. In Caucasian subjects the frequency of the pain-protective GCH1 haplotype was no different in the control group (n = 236), CP patients (n = 265), RAP patients (N = 131), or in CP patients subclassified by pain category compared to previously reported haplotype frequencies in the general Caucasian population. Conclusion: The GCH1 pain-protective haplotype does not have a significant effect on pain patterns or severity in RAP or CP. These results are important for helping to define the regulators of visceral pain, and to distinguish different mechanisms of pain.
- 1 January 2008
- Published by SAGE Publications in Molecular Pain
- Vol. 4, 58
Open AccessDoes the Pain-Protective GTP Cyclohydrolase Haplotype Significantly Alter the Pattern or Severity of Pain in Humans with Chronic Pancreatitis?
Background: Pain is often a dominant clinical feature of chronic pancreatitis but the frequency and severity is highly variable between subjects. We hypothesized that genetic polymorphisms contribute to variations in clinical pain patterns. Since genetic variations in the GTP cyclohydrolase (GCH1) gene have been reported to protect some patients from pain, we investigated the effect of the “pain protective haplotype” in well characterized patients with chronic pancreatitis (CP) or recurrent acute pancreatitis (RAP) from the North American Pancreatitis Study 2 (NAPS2). Results: Subjects in the NAPS2 study were asked to rank their pain in one of 5 categories reflecting different levels of pain frequency and severity. All subjects were genotyped at rs8007267 and rs3783641 to determine the frequency of the GCH1 pain-protective haplotype. In Caucasian subjects the frequency of the pain-protective GCH1 haplotype was no different in the control group (n = 236), CP patients (n = 265), RAP patients (N = 131), or in CP patients subclassified by pain category compared to previously reported haplotype frequencies in the general Caucasian population. Conclusion: The GCH1 pain-protective haplotype does not have a significant effect on pain patterns or severity in RAP or CP. These results are important for helping to define the regulators of visceral pain, and to distinguish different mechanisms of pain.
- 1 June 2006
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 78 (6) , 1035-1045
Ordered Genotypes: An Extended ITO Method and a General Formula for Genetic Covariance
- 1 June 2006
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 78 (6) , 1035-1045
Ordered Genotypes: An Extended ITO Method and a General Formula for Genetic Covariance